RPTH Journal/LinkedIn
Sep 7, 2025, 14:11
New RPTH Journal Research: Statins Reduce Thrombosis Risk but Not Severity of Pulmonary Embolism
RPTH Journal shared a post on LinkedIn:
”Recent studies suggest that statins may reduce the incidence of thrombosis in patients taking statins, but do statins impact severity?
This single-center retrospective study of nearly 1600 individuals suggest that statins don’t affect severity or outcomes of pulmonary embolism.”
Read the full study here.
Title: The impact of statins on pulmonary embolism severity – a retrospective data analysis
Authors: Paul Gressenberger, Bettina Wachmann, Andrea Borenich, Gudrun Pregartner, Lisa Moser, Nikolaus Schreiber, Johannes Schmid, Ewald Kolesnik, Günther Silbernagel, Reinhard B. Raggam, Marianne Brodmann, Thomas Gary

Stay updated with Hemostasis Today.
Andrea Borenich
Bettina Wachmann
Ewald Kolesnik
Gudrun Pregartner
Günther Silbernagel
Health
Hematology
Hemostasis
Hemostasis Today
International Society on Thrombosis and Haemostasis
ISTH
Johannes Schmid
Lisa Moser
Marianne Brodmann
Medicine
Nikolaus Schreiber
Paul Gressenberger
PE
Pulmonary embolism
Reinhard B. Raggam
retrospective analysis
rpth
RPTH Journal
statins
Thomas Gary
thrombosis
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis